News
The Michael J. Fox Foundation Announces Fourth Quarter Participants in Partnering Program Between Awardees and Industry
November 15, 2012 2:01 pm | by Bio-Medicine.Org | CommentsNEW YORK, Nov. 15, 2012 /PRNewswire-USNewswire/ -- The Michael J. Fox Foundation (MJFF) has announced fourth-quarter 2012 participants in its Partnering Program. Selected from the most promising research projects in the MJFF portfolio, Partnering Program participants' research projects are presented directly to industry groups who may wish to invest in further development of the project. By conn...
GPOs: Novation and Premier ink new deals
November 15, 2012 1:24 pm | by Mass Device | CommentsHospital group purchasing organizations Novation and Premier healthcare alliance tout new contract for peripheral vascular and pediatric products. / Group purchasing organization Novation awarded a contract to Cook Medical for devices including biopsy needles, balloons, balloon stents and more. The contract, which takes effect at the beginning of next year, includes Cook's peripheral vascular intervention and diagnostics portfolio, which Novation will offer to its more than 65,000 members and affiliates of VHA Inc., UHC, Children's Hospital Association and Provista, according to the press release. News Well, Deals Roundup, Group Purchasing Organizationsread more
Medivo Appoints Dr. David B. Nash to Its Medical Advisory Board
November 15, 2012 10:00 am | by The Associated Press | CommentsNEW YORK--(BUSINESS WIRE)--Nov 15, 2012--Medivo Inc., a health monitoring company for physicians and their patients, today announced that it has appointed David B. Nash, M.D., MBA, to its Medical Advisory Board, which was established in 2010 to provide strategic advice and counsel in the areas of...
Solos Endoscopy Reports Book Value of $2,393,522 for Period Ended September 30, 2012
November 15, 2012 9:33 am | by The Associated Press | CommentsSolos Endoscopy, Inc. (OTCPK: SNDY) is pleased to announce that the Company has posted its financial results for the period ended September 30, 2012. Solos Endoscopy posted total assets of $2,490,394 compared to total liabilities of just $96,872 for the same period. As a result the Company...
Medisafe 1 Technologies Signs the $7MM Perpetual License Agreement
November 15, 2012 9:28 am | by Bio-Medicine.Org | CommentsJERUSALEM, November 15, 2012 /- Medisafe 1 Technologies Corp. (OTCBB: MFTH), a developer of patented technologies that physically prevent unauthorized administration of prescription medications, announced today that the company has signed a $7MM non-exclusive perpetual license sale agreement to transfer rights for the full commercialization, marketing and distribution of its paten...
Vasomedical Named on Deloitte's 2012 Technology Fast 500 List
November 15, 2012 9:28 am | by Bio-Medicine.Org | CommentsWESTBURY, N.Y., Nov. 15, 2012 /- Vasomedical, Inc. ("Vasomedical") (OTCQB: VASO), a diversified medical technology company specializing in the design, manufacture and sale of medical devices for noninvasive cardiology including EECP ® systems, the gold standard of ECP therapy, announced today that it was named to Deloitte's Technology Fast 500™, a ranking of the...
DebMed to Participate in 24th Annual National Forum On Quality Improvement in Health Care
November 15, 2012 9:28 am | by Bio-Medicine.Org | CommentsCHARLOTTE, N.C., Nov. 15, 2012 /- DebMed ® , creator of the world's first electronic hand hygiene compliance monitoring system based on the World Health Organization's (WHO's) "Five Moments for Hand Hygiene," will feature the DebMed® GMS™ (Group Monitoring System) at the upcoming Institute for Healthcare Improvement's (IHI) 24 th Annual National Forum on Qual...
Karen E. Knudsen, Ph.D., Named New Editor-in-chief of AACR Journal Molecular Cancer Research
November 15, 2012 9:00 am | by AACR | CommentsPHILADELPHIA — The American Association for Cancer Research is pleased to announce Karen E. Knudsen, Ph.D., professor and Hilary Koprowski chair in the departments of cancer biology, urology and radiation oncology at Thomas Jefferson University in Philadelphia, and deputy director for basic science of the NCI-designated Kimmel Cancer Center as the new editor-in-chief of Molecular [...]
Novation Awards Contract to Cook Medical for Peripheral Vascular Products
November 15, 2012 9:00 am | by The Associated Press | CommentsBLOOMINGTON, Ind.--(BUSINESS WIRE)--Nov 15, 2012--Reinforcing its commitment to advancing interventional techniques and technologies to treat disease, Cook Medical is pleased to announce a new contract with leading health care supply chain and contracting company Novation for Cook’s peripheral...
Gore REDUCE Clinical Study Principal Investigators Respond to Recent RESPECT Clinical Trial and PC Trial Results
November 15, 2012 8:00 am | by The Associated Press | CommentsFLAGSTAFF, Ariz.--(BUSINESS WIRE)--Nov 15, 2012--W. L. Gore & Associates (Gore) today released the following statement from the Gore REDUCE Clinical Study Principal Investigators on behalf of the Gore REDUCE Clinical Study Steering Committee in response to the recent RESPECT Clinical Trial and...
Exact Sciences Completes Enrollment of DeeP-C Clinical Trial for Colorectal Cancer Screening
November 15, 2012 7:30 am | by The Associated Press | CommentsMADISON, Wis.--(BUSINESS WIRE)--Nov 15, 2012--Exact Sciences Corp. (Nasdaq: EXAS) today announced it has completed patient enrollment in its DeeP-C pivotal trial for colorectal cancer screening. The study enrolled more than 12,700 patients at sites in the United States and Canada. Senior Research...
EnteroMedics to Present at the Piper Jaffray 24th Annual Healthcare Conference
November 15, 2012 7:00 am | by The Associated Press | CommentsEnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that Mark B. Knudson, Ph.D., EnteroMedics' President and Chief Executive Officer, is scheduled to...
CardioDx Announces Data Demonstrating the Clinical Utility of Its Gene Expression Test for Obstructive Coronary Artery Disease in Patients 65 or Older
November 15, 2012 7:00 am | by The Associated Press | CommentsPALO ALTO, Calif.--(BUSINESS WIRE)--Nov 15, 2012--CardioDx, Inc., a pioneer in the field of cardiovascular genomic diagnostics, today announced results from a study evaluating the impact of the Corus ® CAD gene expression test on clinician decision-making in the assessment of patients with...
Potential New Technique for Anticancer Radiotherapy Could Provide Alternative to Brachytherapy
November 15, 2012 12:05 am | by AACR | CommentsNew approach could be alternative to surgical implantation of radioactive “seeds.” Injected radioactive substance was retained in tumors in mice. Tumor growth was delayed in all treated animals. PHILADELPHIA — A promising new approach to treating solid tumors with radiation was highly efficacious and minimally toxic to healthy tissue in a mouse model of cancer, [...]
Allied Minds pumps $1M into cardiac tool developer
November 15, 2012 12:00 am | by Mass High Tech: The Journal of New England Technology | CommentsAllied Minds, an investment firm in Boston that says it bridges the gap between basic research and commercialization, has launched a new medical technology company.
